OBJECTIVES: As a result of this activity, the participant should be able to:
1. Discuss the various roles of dopamine agonists in psychiatry.
2. Identify the risks of dopamine agonists, including inducing impulse control disorders.
3. Assess the appropriateness of utilizing dopamine agonists in clinical practice.

FACULTY DISCLOSURE: Austin A. Dornon, MD has no relevant financial relationships to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

PLANNERS DISCLOSURE:  Louis A. Gamino, PhD, ABPP, FT and James Bourgeois, O.D., M.D. have no relevant financial relationships to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NOTE:  ADD WEBEX/TEAMS Meeting Invitation link